![Philip Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Huang
Directeur Général chez
TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED
Profil
Kuo Long Huang is currently the Chairman, Chief Executive Officer, General Manager, and Spokesman at TaiGen Biopharmaceuticals Holdings Ltd. He started this position in 2019.
Prior to his current role, he has a background in business administration, having obtained an MBA from the University of South Australia.
He also has an undergraduate degree from Taipei Medical University.
Postes actifs de Philip Huang
| Sociétés | Poste | Début |
|---|---|---|
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Directeur Général | 02/01/2019 |
Formation de Philip Huang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of South Australia
 University of South Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taipei Medical University
 Taipei Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TaiGen Biopharmaceuticals Holdings Ltd.
 TaiGen Biopharmaceuticals Holdings Ltd. BiotechnologyHealth Technology Develops novel therapeutics for infectious diseases, cancer, and diabetes-related complications | Health Technology |
